Pemetrexed acid oxo impurity
An impurity of Pemetrexed which was approved by the United States Food and Drug administration in 2004 for the treatment of malignant pleural mesothelioma (MPM) in combination with cisplatin, a platinum-containing chemotherapeutic drug.
| Supplier | BOC Sciences |
|---|---|
| Product # | 193265-47-3 |
| Pricing | Inquire |
| Cas | 193265-47-3 |
| Molecular Weight | 314.3 |
| Molecular Formula | C15H14N4O4 |
| Canonical SMILES | C1=CC(=CC=C1CCC2C3=C(NC2=O)N=C(NC3=O)N)C(=O)O |